awards per firm. The loss of the last nine or sixteen (choose the cutoff) of the ViaSat Phase II awards and the resulting Phase III would have materially reduced the contributions of ViaSat. We know that very few awards and very few SBIR companies succeed in achieving significant innovation, significant impact on meeting agency needs, and large-scale commercialization. Is SBIR best spent nurturing proven winners or in spreading it thinly with no focus on successful commercialization?

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement